D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 122 Citations 66,123 383 World Ranking 1407 National Ranking 46

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

Guido Reifenberger mainly focuses on Cancer research, Pathology, Glioma, DNA methylation and Internal medicine. His work deals with themes such as Mutation, Gene, Molecular biology, Tumor suppressor gene and Comparative genomic hybridization, which intersect with Cancer research. Guido Reifenberger has researched Pathology in several fields, including Anaplastic astrocytoma, Astrocytoma and Cell culture.

His biological study focuses on Diffuse Astrocytoma. The study incorporates disciplines such as Bioinformatics, Biomarker, Epigenetics, Methyltransferase and Candidate gene in addition to DNA methylation. His biological study spans a wide range of topics, including Surgery and Oncology.

His most cited work include:

  • The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. (6125 citations)
  • International network of cancer genome projects (1611 citations)
  • The WHO Classification of Tumors of the Nervous System (1559 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Cancer research, Glioma, Pathology, Internal medicine and DNA methylation. His research on Cancer research also deals with topics like

  • Molecular biology that intertwine with fields like Comparative genomic hybridization,
  • Loss of heterozygosity most often made with reference to Tumor suppressor gene. As a member of one scientific family, he mostly works in the field of Glioma, focusing on IDH1 and, on occasion, Isocitrate dehydrogenase.

His Pathology research includes themes of Molecular genetics and Astrocytoma, Oligodendroglioma. His Internal medicine research is multidisciplinary, relying on both Glioblastoma, Surgery and Oncology. His research in DNA methylation intersects with topics in Methylation and Epigenetics.

He most often published in these fields:

  • Cancer research (44.33%)
  • Glioma (38.03%)
  • Pathology (34.66%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (44.33%)
  • Glioma (38.03%)
  • Internal medicine (18.49%)

In recent papers he was focusing on the following fields of study:

Guido Reifenberger spends much of his time researching Cancer research, Glioma, Internal medicine, Oncology and DNA methylation. His work deals with themes such as Phenotype, Regulation of gene expression and Gene, which intersect with Cancer research. His studies in Glioma integrate themes in fields like Isocitrate dehydrogenase and CDKN2A.

His Oncology research integrates issues from Chemotherapy, Proportional hazards model, Recurrent glioblastoma, Glioblastoma and Cohort. His research integrates issues of Hazard ratio, Methylation, Mutation, IDH1 and Meningioma in his study of DNA methylation. His Pathology study integrates concerns from other disciplines, such as Tumor progression and Frameshift mutation.

Between 2018 and 2021, his most popular works were:

  • Pan-cancer analysis of whole genomes (538 citations)
  • Longitudinal molecular trajectories of diffuse glioma in adults (92 citations)
  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. (87 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

His primary areas of investigation include Cancer research, Glioma, Temozolomide, Brain tumor and Internal medicine. Guido Reifenberger interconnects Phenotype, BRAF V600E, Cell cycle, Regulation of gene expression and MYB in the investigation of issues within Cancer research. His Glioma study incorporates themes from Immunoediting, Somatic hypermutation and IDH1.

Brain tumor is a subfield of Pathology that he investigates. His Pathology study frequently draws connections to other fields, such as Frameshift mutation. In his research on the topic of Internal medicine, Chemotherapy, Not Otherwise Specified, Astrocytic glioma, Diffuse Astrocytoma and Glioblastoma is strongly related with Oncology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

David N. Louis;Arie Perry;Guido Reifenberger;Andreas von Deimling.
Acta Neuropathologica (2016)

8837 Citations

The WHO Classification of Tumors of the Nervous System

Paul Kleihues;David N. Louis;Bernd W. Scheithauer;Lucy B. Rorke.
Journal of Neuropathology and Experimental Neurology (2002)

2716 Citations

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones.
Nature (2012)

1923 Citations

International network of cancer genome projects

Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
Nature (2010)

1460 Citations

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang.
Cancer Cell (2012)

1438 Citations

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

Christian Hartmann;Christian Hartmann;Jochen Meyer;Jörg Balss;David Capper.
Acta Neuropathologica (2009)

1089 Citations

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.

Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik.
Acta Neuropathologica (2011)

1084 Citations

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

Wolfgang Wick;Michael Platten;Christoph Meisner;Joerg Felsberg.
Lancet Oncology (2012)

936 Citations

Long-term survival with glioblastoma multiforme

Dietmar Krex;Barbara Klink;Christian Hartmann;Andreas Von Deimling.
Brain (2007)

891 Citations

DNA methylation-based classification of central nervous system tumours

David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt.
Nature (2018)

860 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Guido Reifenberger

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 495

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 383

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 261

Michael Weller

Michael Weller

University of Zurich

Publications: 237

Felix Sahm

Felix Sahm

University Hospital Heidelberg

Publications: 225

David Capper

David Capper

Humboldt-Universität zu Berlin

Publications: 211

Michael D. Taylor

Michael D. Taylor

University of Toronto

Publications: 208

David T. W. Jones

David T. W. Jones

German Cancer Research Center

Publications: 204

Marcel Kool

Marcel Kool

German Cancer Research Center

Publications: 172

Arie Perry

Arie Perry

University of California, San Francisco

Publications: 159

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 146

Pieter Wesseling

Pieter Wesseling

University of Amsterdam

Publications: 140

Peter Lichter

Peter Lichter

German Cancer Research Center

Publications: 136

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 130

Torsten Pietsch

Torsten Pietsch

University of Bonn

Publications: 128

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 126

Trending Scientists

Ivar Ekeland

Ivar Ekeland

University of British Columbia

Stéphane Petoud

Stéphane Petoud

Centre national de la recherche scientifique, CNRS

Jordi Segura

Jordi Segura

Pompeu Fabra University

Giovanni Palmisano

Giovanni Palmisano

Khalifa University

Walter Goessler

Walter Goessler

University of Graz

Bojja Sreedhar

Bojja Sreedhar

Indira Gandhi Centre for Atomic Research

Albert Schinzel

Albert Schinzel

University of Zurich

Jeffrey L. Boore

Jeffrey L. Boore

University of California, Berkeley

Steven J. Knapp

Steven J. Knapp

University of California, Davis

Wataru Yamori

Wataru Yamori

University of Tokyo

Outi Hovatta

Outi Hovatta

Karolinska Institute

Jun Wu

Jun Wu

The University of Texas Southwestern Medical Center

Alex J. Cannon

Alex J. Cannon

University of Victoria

Marleen Boelaert

Marleen Boelaert

Institute of Tropical Medicine Antwerp

Kenneth L. Mattox

Kenneth L. Mattox

Baylor College of Medicine

Jennifer D. Allen

Jennifer D. Allen

Tufts University

Something went wrong. Please try again later.